238 related articles for article (PubMed ID: 20400365)
1. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
[TBL] [Abstract][Full Text] [Related]
3. Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinoma.
Janus JR; Laborde RR; Greenberg AJ; Wang VW; Wei W; Trier A; Olsen SM; Moore EJ; Olsen KD; Smith DI
Laryngoscope; 2011 Dec; 121(12):2598-603. PubMed ID: 22109759
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
Umair A; Tarakji B; Ibrahim A; Nasser A; Fq A; Shreen A
Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
[TBL] [Abstract][Full Text] [Related]
6. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation.
Qadir F; Aziz MA; Sari CP; Ma H; Dai H; Wang X; Raithatha D; Da Silva LGL; Hussain M; Poorkasreiy SP; Hutchison IL; Waseem A; Teh MT
Mol Cancer; 2018 Jul; 17(1):97. PubMed ID: 30008265
[TBL] [Abstract][Full Text] [Related]
9. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
[TBL] [Abstract][Full Text] [Related]
10. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
[TBL] [Abstract][Full Text] [Related]
11. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
[TBL] [Abstract][Full Text] [Related]
12. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
14. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck.
Thurfjell N; Coates PJ; Boldrup L; Lindgren B; Bäcklund B; Uusitalo T; Mahani D; Dabelsteen E; Dahlqvist A; Sjöström B; Roos G; Vojtesek B; Nenutil R; Nylander K
Adv Otorhinolaryngol; 2005; 62():49-57. PubMed ID: 15608417
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma.
Lu Y; Shen Y; Li L; Zhang M; Wang M; Ge L; Yang J; Tang X
Anal Cell Pathol (Amst); 2021; 2021():5510753. PubMed ID: 34055579
[TBL] [Abstract][Full Text] [Related]
16. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
18. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Chen CH; Chien CY; Huang CC; Hwang CF; Chuang HC; Fang FM; Huang HY; Chen CM; Liu HL; Huang CY
Oncogene; 2009 Jul; 28(30):2723-37. PubMed ID: 19525975
[TBL] [Abstract][Full Text] [Related]
19. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]